Biopharma Deals and Funding Trends – Review of 2022 and Updates through Q1 2023

by Apr 3, 2023Analysis, Funding, M&A, Partnership Deals

Deal Flow in 2022 Returned to pre-2019 Levels

 

Chart showing number of healthcare and life sciences deals by deal type

 

 

Lower Deal Dollars Across All Healthcare and Life Sciences

 

Lower Deal Dollars Across All Healthcare and Life Sciences

 

Licensing Terms are Shifting to More in Milestones

 

Licensing Terms are Shifting to More in Milestones

 

Large Cap Biopharma In-Licensing and Buying in 2022

 

Large Cap Biopharma In-Licensing and Buying in 2022

Big Pharma Pays Well for Phase II as POC Returns

 

Big Pharma Pays Well for Phase II as POC Returns

Large Cap Biopharma Therapy Areas and Modalities in Focus

 

Large Cap Biopharma Therapy Areas and Modalities in Focus

R&D Partnership Activity in Oncology

 

R&D Partnership Activity in Oncology

R&D Partnership Activity in Neurology

 

R&D Partnership Activity in Neurology

R&D Partnership Upfronts in the Top Modalities

 

R&D Partnership Upfronts in the Top Modalities

Healthcare and Life Sciences Venture Returned to pre-2020

 

Healthcare and Life Sciences Venture Returned to pre-2020

All Company Stages Saw Lower Venture Activity

 

All Company Stages Saw Lower Venture Activity

Biopharma M&A Volume Increased in Q1

 

Biopharma M&A Volume Increased in Q1

20,378

Licensing Deals

17,730

Funding Rounds

4,034

M&A

31,012

Company Profiles

5,478

Other Deals

26,505

Drug Sales Figures

All of this by stage, disease indication, modality, target...

More Research by DealForma

Introducing: DealForma plus Tableau

Introducing: DealForma plus Tableau

We are excited to introduce DealForma's new Tableau dashboard integration. High quality data on biopharma deals and funding meets interactive charts and visuals. DealForma customers will have exclusive access to the DealForma chart dashboards built on Tableau right...

Venture & IPO – Medtech – Q1 2023 

Venture & IPO – Medtech – Q1 2023 

The Medtech sector encompasses medical devices, diagnostics, and digital health solutions, playing a crucial role in healthcare. In Q1 2022, the medtech, devices, digital health therapeutics, and wearables sector experienced a strong opening with 95 funding rounds and...